UnitedHealth Group Incorporated (UNH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $365.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
UnitedHealth Group Incorporated (UNH) Financials: Revenue, Profit and Cash Flow
UnitedHealth Group reported revenue of $447.57B for the fiscal year ended Dec 31, 2025, up 11.8% from the year before. That year, net income was $12.81B with a net margin of 2.9%, operating cash flow was $19.70B and free cash flow was $16.07B. The quarter ended Sep 30, 2026 had revenue of $112.69B and net income of $4.30B.
Revenue and Margins
The operating margin was 4.2% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $184.84B, a compound annual rate of 10.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $447.57B | +11.8% | 18.5% | 4.2% | 2.9% |
| Dec 2024 | $400.28B | +7.7% | 22.3% | 8.1% | 3.8% |
| Dec 2023 | $371.62B | +14.6% | 24.5% | 8.7% | 6.2% |
| Dec 2022 | $324.16B | +12.7% | 24.6% | 8.8% | 6.4% |
| Dec 2021 | $287.60B | +11.8% | 89.2% | 8.3% | 6.2% |
| Dec 2020 | $257.14B | +6.2% | 88.0% | 8.7% | 6.1% |
| Dec 2019 | $242.16B | +7.0% | 88.4% | 8.1% | 5.9% |
| Dec 2018 | $226.25B | +12.5% | 88.1% | 7.7% | 5.5% |
| Dec 2017 | $201.16B | +8.8% | 88.0% | 7.6% | 5.4% |
| Dec 2016 | $184.84B | N/A | 86.8% | 7.0% | 3.8% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 15.9% from the year before. In the quarter ended Sep 2026, net income rose 69.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B |
| Cost of revenue | $364.65B | $310.88B | $280.66B | $244.54B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B |
| Gross profit | $82.92B | $89.40B | $90.96B | $79.62B | $256.56B | $226.40B | $214.04B | $199.25B | $177.05B | $160.42B |
| Operating income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B |
| Net income | $12.81B | $15.24B | $23.14B | $20.64B | $17.73B | $15.77B | $14.24B | $12.38B | $10.82B | $7.07B |
| EBITDA | $23.06B | N/A | $36.33B | $31.84B | $27.07B | $25.30B | $22.41B | $19.77B | $17.45B | $14.98B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.69B | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B |
| Gross profit | $22.00B | $23.30B | $25.41B | $18.49B | $20.64B | $20.01B | $23.77B | $21.31B | $23.03B | $22.06B | $23.00B | $22.00B |
| Operating income | $6.56B | $7.99B | $8.99B | $380.00M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B |
| Net income | $4.30B | $5.67B | $6.48B | $218.00M | $2.54B | $3.57B | $6.47B | $5.78B | $6.26B | $4.42B | -$1.22B | $5.67B |
Balance Sheet
As of Dec 2025, total debt of $78.39B exceeded cash and equivalents by $54.02B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B |
| Current assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B |
| Cash and equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B |
| Total liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B |
| Short-term debt | $6.07B | $4.54B | $4.27B | $3.11B | $3.62B | $4.82B | $3.87B | $1.97B | $2.86B | $7.19B |
| Long-term debt | $72.32B | $72.36B | $58.26B | $54.51B | $42.38B | $38.65B | $36.81B | $34.58B | $28.84B | $25.78B |
| Shareholder equity | $94.11B | $92.66B | $88.76B | $77.77B | $71.76B | $65.49B | $57.62B | $51.70B | $47.78B | $38.27B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $312.78B | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B |
| Total liabilities | $207.24B | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | $174.80B |
| Cash and equivalents | $25.84B | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | $25.43B |
| Shareholder equity | $98.10B | $98.45B | $97.88B | $94.11B | $95.79B | $94.72B | $95.04B | $92.66B | $94.53B | $89.36B | $86.69B | $88.76B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 81.6% of operating cash flow. Dividends and share repurchases together came to 84.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B |
| Capital expenditures | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B |
| Free cash flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B |
| Dividends paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B |
| Share repurchases | $5.71B | $9.28B | $8.73B | $7.18B | $6.34B | $4.25B | $6.12B | $4.50B | $1.50B | $1.28B |
| Investing cash flow | -$8.69B | -$20.53B | -$15.57B | -$28.48B | -$10.37B | -$12.53B | -$12.70B | -$12.38B | -$8.60B | -$9.36B |
| Financing cash flow | -$11.64B | -$3.51B | -$11.53B | $4.23B | -$7.46B | -$3.59B | -$5.63B | -$4.37B | -$3.44B | -$1.01B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.12B | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | -$5.19B |
| Capital expenditures | $859.00M | $799.00M | $763.00M | $948.00M | $890.00M | $886.00M | $898.00M | $912.00M | $991.00M | $853.00M | $743.00M | $959.00M |
| Free cash flow | $4.26B | $10.25B | $8.15B | $160.00M | $5.05B | $6.30B | $4.56B | $1.46B | $12.95B | $5.89B | $401.00M | -$6.15B |
Frequently Asked Questions About UNH
What is UnitedHealth Group's annual revenue?
UnitedHealth Group reported revenue of $447.57B for the fiscal year ended Dec 31, 2025.
How fast is UnitedHealth Group's revenue growing?
Revenue was up 11.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.4%.
Is UnitedHealth Group profitable?
Yes. UnitedHealth Group reported net income of $12.81B for the fiscal year ended Dec 31, 2025, with a net margin of 2.9%.
How much free cash flow does UNH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $19.70B minus capital expenditures of $3.62B produced free cash flow of $16.07B.
How much debt does UnitedHealth Group have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $72.32B, short-term debt of $6.07B and cash and equivalents of $24.36B.
UNH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts